264 related articles for article (PubMed ID: 20185816)
1. Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.
Ramnanan CJ; Edgerton DS; Rivera N; Irimia-Dominguez J; Farmer B; Neal DW; Lautz M; Donahue EP; Meyer CM; Roach PJ; Cherrington AD
Diabetes; 2010 Jun; 59(6):1302-11. PubMed ID: 20185816
[TBL] [Abstract][Full Text] [Related]
2. Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.
Torres TP; Sasaki N; Donahue EP; Lacy B; Printz RL; Cherrington AD; Treadway JL; Shiota M
J Pharmacol Exp Ther; 2011 Jun; 337(3):610-20. PubMed ID: 21363927
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs.
Shiota M; Jackson PA; Bischoff H; McCaleb M; Scott M; Monohan M; Neal DW; Cherrington AD
Am J Physiol; 1997 Nov; 273(5):E868-79. PubMed ID: 9374671
[TBL] [Abstract][Full Text] [Related]
4. Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.
Edgerton DS; Cardin S; Neal D; Farmer B; Lautz M; Pan C; Cherrington AD
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E510-22. PubMed ID: 14644767
[TBL] [Abstract][Full Text] [Related]
5. Effects of insulin deficiency or excess on hepatic gluconeogenic flux during glycogenolytic inhibition in the conscious dog.
Edgerton DS; Cardin S; Pan C; Neal D; Farmer B; Converse M; Cherrington AD
Diabetes; 2002 Nov; 51(11):3151-62. PubMed ID: 12401705
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.
Sindelar DK; Balcom JH; Chu CA; Neal DW; Cherrington AD
Diabetes; 1996 Nov; 45(11):1594-604. PubMed ID: 8866566
[TBL] [Abstract][Full Text] [Related]
7. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
Oakes ND; Cooney GJ; Camilleri S; Chisholm DJ; Kraegen EW
Diabetes; 1997 Nov; 46(11):1768-74. PubMed ID: 9356024
[TBL] [Abstract][Full Text] [Related]
9. Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.
Edgerton DS; Ramnanan CJ; Grueter CA; Johnson KM; Lautz M; Neal DW; Williams PE; Cherrington AD
Diabetes; 2009 Dec; 58(12):2766-75. PubMed ID: 19755527
[TBL] [Abstract][Full Text] [Related]
10. A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin.
Winnick JJ; An Z; Moore MC; Ramnanan CJ; Farmer B; Shiota M; Cherrington AD
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E358-66. PubMed ID: 19470836
[TBL] [Abstract][Full Text] [Related]
11. Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs.
Ramnanan CJ; Saraswathi V; Smith MS; Donahue EP; Farmer B; Farmer TD; Neal D; Williams PE; Lautz M; Mari A; Cherrington AD; Edgerton DS
J Clin Invest; 2011 Sep; 121(9):3713-23. PubMed ID: 21865644
[TBL] [Abstract][Full Text] [Related]
12. Hyperinsulinemia compensates for infection-induced impairment in net hepatic glucose uptake during TPN.
Donmoyer CM; Chen SS; Hande SA; Lacy DB; Ejiofor J; McGuinness OP
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E235-43. PubMed ID: 10913021
[TBL] [Abstract][Full Text] [Related]
13. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast.
Hendrick GK; Frizzell RT; Williams PE; Cherrington AD
Am J Physiol; 1990 May; 258(5 Pt 1):E841-9. PubMed ID: 2185665
[TBL] [Abstract][Full Text] [Related]
14. Regulation of glucose production by NEFA and gluconeogenic precursors during chronic glucagon infusion.
McGuinness OP; Ejiofor J; Audoly LP; Schrom N
Am J Physiol; 1998 Sep; 275(3):E432-9. PubMed ID: 9725809
[TBL] [Abstract][Full Text] [Related]
15. Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin.
Camacho RC; Pencek RR; Lacy DB; James FD; Wasserman DH
Diabetes; 2004 Feb; 53(2):285-93. PubMed ID: 14747277
[TBL] [Abstract][Full Text] [Related]
16. Similar dose responsiveness of hepatic glycogenolysis and gluconeogenesis to glucagon in vivo.
Stevenson RW; Steiner KE; Davis MA; Hendrick GK; Williams PE; Lacy WW; Brown L; Donahue P; Lacy DB; Cherrington AD
Diabetes; 1987 Mar; 36(3):382-9. PubMed ID: 2879758
[TBL] [Abstract][Full Text] [Related]
17. Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery.
Holste LC; Connolly CC; Moore MC; Neal DW; Cherrington AD
Am J Physiol; 1997 Sep; 273(3 Pt 1):E488-96. PubMed ID: 9316437
[TBL] [Abstract][Full Text] [Related]
18. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog.
McGuinness OP; Murrell S; Moran C; Bracy D; Cherrington AD
Metabolism; 1994 Oct; 43(10):1310-7. PubMed ID: 7934986
[TBL] [Abstract][Full Text] [Related]
19. Effect of a selective rise in sinusoidal norepinephrine on HGP is due to an increase in glycogenolysis.
Chu CA; Sindelar DK; Neal DW; Allen EJ; Donahue EP; Cherrington AD
Am J Physiol; 1998 Jan; 274(1):E162-71. PubMed ID: 9458762
[TBL] [Abstract][Full Text] [Related]
20. Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog.
Shiota M; Galassetti P; Monohan M; Neal DW; Cherrington AD
Diabetes; 1998 Jun; 47(6):867-73. PubMed ID: 9604861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
